IL132570A0 - Cox-2 selective carprofen for treating pain and inflammation in dogs - Google Patents

Cox-2 selective carprofen for treating pain and inflammation in dogs

Info

Publication number
IL132570A0
IL132570A0 IL13257098A IL13257098A IL132570A0 IL 132570 A0 IL132570 A0 IL 132570A0 IL 13257098 A IL13257098 A IL 13257098A IL 13257098 A IL13257098 A IL 13257098A IL 132570 A0 IL132570 A0 IL 132570A0
Authority
IL
Israel
Prior art keywords
carprofen
cox
dogs
inflammation
selective
Prior art date
Application number
IL13257098A
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of IL132570A0 publication Critical patent/IL132570A0/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
IL13257098A 1997-05-05 1998-05-01 Cox-2 selective carprofen for treating pain and inflammation in dogs IL132570A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4563597P 1997-05-05 1997-05-05
PCT/IB1998/000662 WO1998050033A1 (en) 1997-05-05 1998-05-01 Cox-2 selective carprofen for treating pain and inflammation in dogs

Publications (1)

Publication Number Publication Date
IL132570A0 true IL132570A0 (en) 2001-03-19

Family

ID=21939053

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13257098A IL132570A0 (en) 1997-05-05 1998-05-01 Cox-2 selective carprofen for treating pain and inflammation in dogs

Country Status (32)

Country Link
EP (1) EP0988034A1 (en)
JP (1) JP2000513020A (en)
KR (2) KR20040004406A (en)
CN (1) CN1255059A (en)
AP (1) AP9801234A0 (en)
AR (2) AR011726A1 (en)
AU (1) AU6932198A (en)
BG (1) BG103852A (en)
BR (1) BR9808720A (en)
CA (1) CA2288759A1 (en)
DZ (1) DZ2479A1 (en)
EA (1) EA003696B1 (en)
GT (1) GT199800063A (en)
HR (1) HRP980244A2 (en)
HU (1) HUP0001286A3 (en)
ID (1) ID21311A (en)
IL (1) IL132570A0 (en)
IS (1) IS5220A (en)
MA (1) MA26491A1 (en)
NO (1) NO995389L (en)
NZ (1) NZ500183A (en)
OA (1) OA11213A (en)
PA (1) PA8450601A1 (en)
PE (1) PE72599A1 (en)
PL (1) PL337003A1 (en)
SK (1) SK148199A3 (en)
TN (1) TNSN98059A1 (en)
TW (1) TW590773B (en)
UY (1) UY24989A1 (en)
WO (1) WO1998050033A1 (en)
YU (1) YU55899A (en)
ZA (1) ZA983722B (en)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6245797B1 (en) 1997-10-22 2001-06-12 Merck & Co., Inc. Combination therapy for reducing the risks associated with cardio-and-cerebrovascular disease
AU2003204888B2 (en) * 1998-05-22 2005-07-28 Pfizer Products Inc. Treating or Preventing the Early Stages of Degeneration of Articular Cartilage or Subchondral Bone in Mammals Using Carprofen and Derivatives
US6506785B2 (en) * 1998-05-22 2003-01-14 Pfizer, Inc. Treating or preventing the early stages of degeneration of articular cartilage or subchondral bone in mammals using carprofen and derivatives
CA2347365A1 (en) * 1998-10-23 2000-05-04 Merck Frosst Canada & Co. Combination product comprising an e-type prostaglandin ligand and a cox-2 selective inhibitor and methods of use
EP1637137A3 (en) * 1999-03-10 2006-07-05 G.D. Searle LLC Method and composition for administering a cyclooxygenase-2 inhibitor to animals
AU1592901A (en) * 1999-11-11 2001-06-06 Eli Lilly And Company Oncolytic combinations for the treatment of cancer
JP2004521856A (en) * 2000-05-15 2004-07-22 メルク フロスト カナダ アンド カンパニー Combination therapy using a COX-2 selective inhibitor and a thromboxane inhibitor and compositions therefor
BR0111767A (en) 2000-06-13 2003-07-08 Wyeth Corp Analgesic and anti-inflammatory compositions containing cox-2 inhibitors, their use and method for enhancing an analgesic compound
DE10032132A1 (en) * 2000-07-01 2002-01-17 Lohmann Therapie Syst Lts Dermal therapeutic system containing non-steroidal anti-inflammatory drugs with selective COX-2 inhibition
AU2001284753B2 (en) 2000-08-07 2006-10-26 Vanderbilt University Detection of COX-2 activity and anandamide metabolites
WO2003007875A2 (en) * 2001-07-16 2003-01-30 Hoegestaett Edward Compounds with analgesic, antipyretic and/or anti-inflammatory activity
JP4354984B2 (en) 2003-05-07 2009-10-28 オステオロジックス エイ/エス Treatment of cartilage / bone symptoms with water-soluble strontium salts
JP2007500691A (en) * 2003-07-31 2007-01-18 ファルマシア・アンド・アップジョン・カンパニー・エルエルシー Dispersible formulation of anti-inflammatory agent
CA2608010A1 (en) * 2005-05-20 2006-11-23 Pfizer Limited Synergistic combinations of non-steroidal antiinflammatory drugs with alpha-delta-ligands
PT2079456E (en) 2007-04-04 2013-03-13 Sigmoid Pharma Ltd Pharmaceutical cyclosporin compositions
WO2008132707A1 (en) 2007-04-26 2008-11-06 Sigmoid Pharma Limited Manufacture of multiple minicapsules
BRPI1012196B1 (en) 2009-05-18 2021-11-30 Sublimity Therapeutics Limited COMPOSITION INCLUDING OIL DROPS
GB2485327A (en) 2009-08-12 2012-05-09 Sigmoid Pharma Ltd Immunomodulatory compositions comprising a polymer matrix and an oil phase
GB201020032D0 (en) 2010-11-25 2011-01-12 Sigmoid Pharma Ltd Composition
GB201212010D0 (en) 2012-07-05 2012-08-22 Sigmoid Pharma Ltd Formulations
GB201319791D0 (en) 2013-11-08 2013-12-25 Sigmoid Pharma Ltd Formulations
CN105939713A (en) * 2014-03-06 2016-09-14 阿莱塔纳治疗学股份有限公司 Compositions of grapiprant and methods for using same
CN107106644B (en) 2014-11-07 2022-04-15 卓越治疗有限公司 Cyclosporin-containing compositions
EP3242557A4 (en) * 2015-01-09 2018-09-05 Jaguar Health, Inc. Methods of treating diarrhea in companion animals
EP4125874A4 (en) * 2020-03-25 2024-05-01 Stanford Res Inst Int Lipoxygenase inhibitors
US11116737B1 (en) 2020-04-10 2021-09-14 University Of Georgia Research Foundation, Inc. Methods of using probenecid for treatment of coronavirus infections
KR102404883B1 (en) 2020-11-30 2022-06-07 (주)이노보테라퓨틱스 Pharmaceutical composition for preventing or treating keloid or hypertrophic scar comprising Benzbromarone

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3896145A (en) * 1972-07-24 1975-07-22 Hoffmann La Roche Carbazoles
CA1319886C (en) * 1987-02-03 1993-07-06 Alberto Ferro Mixed micelle solutions

Also Published As

Publication number Publication date
GT199800063A (en) 1999-10-26
YU55899A (en) 2003-08-29
EA003696B1 (en) 2003-08-28
NO995389L (en) 2000-01-04
EA199900895A1 (en) 2000-06-26
EP0988034A1 (en) 2000-03-29
NZ500183A (en) 2002-04-26
CN1255059A (en) 2000-05-31
WO1998050033A1 (en) 1998-11-12
JP2000513020A (en) 2000-10-03
TW590773B (en) 2004-06-11
SK148199A3 (en) 2001-09-11
AR011726A1 (en) 2000-08-30
TNSN98059A1 (en) 2005-03-15
PE72599A1 (en) 1999-08-12
IS5220A (en) 1999-10-19
ZA983722B (en) 1999-11-04
AP9801234A0 (en) 1999-11-04
KR20010012300A (en) 2001-02-15
PA8450601A1 (en) 2000-05-24
NO995389D0 (en) 1999-11-04
MA26491A1 (en) 2004-12-20
UY24989A1 (en) 2001-10-25
BG103852A (en) 2000-06-30
HRP980244A2 (en) 1999-02-28
BR9808720A (en) 2000-07-11
OA11213A (en) 2003-07-14
HUP0001286A3 (en) 2000-12-28
AU6932198A (en) 1998-11-27
PL337003A1 (en) 2000-07-31
CA2288759A1 (en) 1998-11-12
AR039628A2 (en) 2005-03-02
KR20040004406A (en) 2004-01-13
ID21311A (en) 1999-05-20
HUP0001286A2 (en) 2000-11-28
DZ2479A1 (en) 2003-02-01

Similar Documents

Publication Publication Date Title
IL132570A0 (en) Cox-2 selective carprofen for treating pain and inflammation in dogs
HUP0004170A3 (en) Methods and materials for treating and preventing inflammation ofmucosal tissue
EP1065978A4 (en) Implantable therapeutic device and method
GB2346809B (en) Heel care device and method
AU7696098A (en) Substance p inhibitors in combination with nmda-blockers for treating pain
IL132758A0 (en) Methods for treating inflammation and inflammatory diseases using padprt
HK1032553A1 (en) Mixing method and mixing device
GB9817618D0 (en) Hair treatment device and method
IL138062A0 (en) Veterinary delivery device and method
EP1049107A4 (en) Substance activating method and device
EP0965840A4 (en) Method for analyzing annexin v in urine and use thereof
EP1099370A4 (en) Livestock raising facility and method
GB9809448D0 (en) Treatment device and method
HUP0004372A3 (en) Water treatment method and device
IL132867A0 (en) Epilation method and device
AU5871898A (en) Microparticles and their use in cancer treatment
GB9707949D0 (en) Water treatment and delivery apparatus
GB2312366B (en) Hoof cleaning and treatment device
GB2339611B (en) Water treatment and delivery apparatus
ZA98793B (en) Microparticles and their use in cancer treatment
GB9818018D0 (en) Microparticles and their use in therapy
GB9907879D0 (en) Hair treatment device and method
TW424591U (en) Polylone waste treatment and regeneration device
GB9718062D0 (en) Hair treatment device and method
GB9720566D0 (en) Hair treatment device and method